FACE TO FACE: Dr Pawan Dhar, Executive Director, CVJ Centre for Synthetic Biology & Biomanufacturing, Kochi

In an exclusive rapid-fire interview on the sidelines of Global Bio India 2024 in New Delhi, Rahul Koul, Chief Editor, BioVoice News spoke to Dr Pawan Dhar, Executive Director, CVJ Centre for Synthetic Biology and Biomanufacturing, Kochi who shared insights on the latest R&D efforts, industry-academia collaboration and startup ecosystem.

Key Questions

♦ Please tell us more about the activities of CVJ Centre for Synthetic Biology and Biomanufacturing, Kochi? What are the key objectives behind your R&D and the product pipeline?

♦ How do you look at the growth of Indian biotechnology industry and startup ecosystem?

♦ What are your views on the policy and the broader US$ 300 billion bioeconomy by 2030?

About Dr Pawan Dhar:

Before taking up his latest role at CVJ Centre for Synthetic Biology and Biomanufacturing, Kochi, Prof Dhar was the Professor and Head, Synthetic Biology group, School of Biotechnology, Jawaharlal Nehru University, New Delhi. He was also a Professor at the Special Centre for Systems medicine and School of Sanskrit and Indic Studies at JNU.

One of his significant contributions has been to develop a novel drug discovery platform from DNA sequences from the dark matter of genome. Prof. Dhar serves on the board of referees for European Science Foundation. In the past, Prof. Dhar has headed RIKEN (Japan) and TCS (Hyderabad) program on metagenomics, established research labs in India, Singapore, and Japan and published in the area of human genetics, systems biology, and synthetic biology covering computational, experimental and policy areas.

Prof. Dhar received his Ph.D. degree in 1993 from BHU (Varanasi) in Human Genetics.

Click here now to watch the full interview for detailed insights.